HCN Essentials: Shingrix Expands Approval; ACE vs. ARB Hypertension Study; Charting ChallengesAugust 03, 2021 | Trending in Healthcare Allergy & Immunology FDA OK’s Shingrix For Immunocompromised Adults The additional approval expands immunization coverage to the most at-risk group for acquiring shingles – the immunocompromised. It also shortens the time to the second dose in the 2-dose Shingrix schedule. Decision support based on the Zoster Efficacy Study in Patients Undergoing HSCT (ZOE-HSCT) phase III trial (JAMA). Read full article Cardiology Hypertension Journal Study: Evaluating ARBs vs. ACE Inhibitors Safety Outcomes Findings: Primary outcomes included AMI, HF, stroke, and CVEs; 51 secondary and safety outcomes included angioedema, cough, syncope, and electrolyte abnormalities. ACE inhibitors were associated with a significantly increased risk of four secondary and safety outcomes compared with ARBs.Design: Multinational cohort study; Patients: ~2.3M ACE, ~674K ARB Read full article Family Medicine/General Practice 3 Mistakes Physicians Make That Triple Charting Time Expecting perfection when it comes to charting? Are you overly self-critical, telling yourself you’ll never get the charts done or you’re just not good at it? Do you go too big, watching your “identity-forming” charting spiral out of control? Keep calm and listen to this KevinMD.com podcast from Dr. Gail Gazelle, an internal medicine physician and the author of the book Everyday Resilience, who shares helpful advice for doctors struggling with these three mistakes. Read full article
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS